Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis.
Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis.
复制标题
用于诊断和治疗动脉粥样硬化的巨噬细胞靶向纳米药物
DOI:
10.3389/fphar.2022.1000316
复制
发表时间:
2022
影响因子:
5.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Atherosclerosis is the primary cause of cardiovascular diseases, such as myocardial infarction and stroke, which account for the highest death toll worldwide. Macrophage is the major contributor to atherosclerosis progression, and therefore, macrophage-associated pathological process is considered an extremely important target for the diagnosis and treatment of atherosclerosis. However, the existing clinical strategies still have many bottlenecks and challenges in atherosclerosis’s early detection and management. Nanomedicine, using various nanoparticles/nanocarriers for medical purposes, can effectively load therapeutic agents, significantly improve their stability and accurately deliver them to the atherosclerotic plaques. In this review, we summarized the latest progress of the macrophage-targeted nanomedicine in the diagnosis and treatment of atherosclerosis, and their potential applications and clinical benefits are also discussed.
登录
查看更多内容
影响因子:
16.1
作者:
Atukorale PU;Covarrubias G;Bauer L;Karathanasis E
通讯作者:
Karathanasis E
影响因子:
9.5
作者:
Di Francesco, Valentina;Gurgone, Danila;Decuzzi, Paolo
通讯作者:
Decuzzi, Paolo
影响因子:
9.5
作者:
Cheng, Dengfeng;Li, Xiao;Shi, Hongcheng
通讯作者:
Shi, Hongcheng
影响因子:
17.1
作者:
Kamaly, Nazila;Fredman, Gabrielle;Fojas, Jhalique Jane R.;Subramanian, Manikandan;Choi, Won Ii;Zepeda, Katherine;Vilos, Cristian;Yu, Mikyung;Gadde, Suresh;Wu, Jun;Milton, Jaclyn;Leitao, Renata Carvalho;Fernandes, Livia Rosa;Hasan, Moaraj;Gao, Huayi;Vance Nguyen;Harris, Jordan;Tabas, Ira;Farokhzad, Omid C.
通讯作者:
Farokhzad, Omid C.
影响因子:
14
作者:
Aviv, Hagit;Bartling, Sonke;Margel, Shlomo
通讯作者:
Margel, Shlomo